TRAPPC10

Across TCGA pan-cancer cohorts, TRAPPC10 mass-spec protein is linked to patient survival in 6 of 34 cancer types, making it a survival-associated TRAPPC10 data layer compared with 27 for mass-spec protein and 5 for mutation status.

The strongest signal is observed in lung adenocarcinoma (LUAD), where higher TRAPPC10 mass-spec protein is associated with worse overall survival. In most high-consensus cancer types, elevated TRAPPC10 expression acts as an unfavorable survival marker, although some lineages such as CCRCC and PDAC show a favorable association.

LUAD, GBM, and CCRCC are the cancer types where TRAPPC10 mass-spec protein most reproducibly stratifies survival.

mass-spec protein survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
LUAD	OS	Median	II,III,IV	0.511	0.804	.025	10	view →
GBM	DFS	Quartile	All	0.210	0.510	.026	6	view →
CCRCC	DFS	Median	II,III,IV	1.000	0.514	.022	6	view →
PDAC	OS	Tertile	All	0.901	0.785	.026	3	view →
LSCC	OS	Tertile	II,III,IV	0.502	0.862	.029	3	view →
HNSC	OS	Median	III,IV	0.547	0.782	.023	1	view →

Pink = unfavorable, green = favorable. Showing the 6 strongest of 6 lineages.

TRAPPC10–LUAD (OS)

Open the LUAD breakdown →